Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Cardiovascular·MeSH: Hypoxia

Prevalence

47000.0 / 100K

Incidence

3000.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Pulmonary Hypertension Due to Lung Diseases and Hypoxia?

There are 1 clinical trial targeting Pulmonary Hypertension Due to Lung Diseases and Hypoxia tracked by BioSniper.

What is the prevalence of Pulmonary Hypertension Due to Lung Diseases and Hypoxia?

The estimated prevalence of Pulmonary Hypertension Due to Lung Diseases and Hypoxia is approximately 47000.0 per 100,000 population.

Deep-dive into Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Pulmonary Hypertension Due to Lung Diseases and Hypoxia — Drugs in Development & Clinical Trials | BioSniper